BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Anupam K, Tusharkant C, Gupta SD, Ranju R. Loss of disabled-2 expression is an early event in esophageal squamous tumorigenesis. World J Gastroenterol 2006; 12(37): 6041-6045 [PMID: 17009406 DOI: 10.3748/wjg.v12.i37.6041]
URL: https://www.wjgnet.com/1007-9327/full/v12/i37/6041.htm
Number Citing Articles
1
Hsi-Wen Yeh, Szu-Shuo Lee, Chieh-Yu Chang, Yaw-Dong Lang, Yuh-Shan Jou. A New Switch for TGFβ in CancerCancer Research 2019; 79(15): 3797 doi: 10.1158/0008-5472.CAN-18-2019
2
Kai Ma, Baoping Cao, Mingzhou Guo. The detective, prognostic, and predictive value of DNA methylation in human esophageal squamous cell carcinomaClinical Epigenetics 2016; 8(1) doi: 10.1186/s13148-016-0210-9
3
L Du, Z Zhao, X Ma, T-H Hsiao, Y Chen, E Young, M Suraokar, I Wistuba, J D Minna, A Pertsemlidis. miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancerOncogene 2014; 33(34): 4307 doi: 10.1038/onc.2013.381
4
Robert Moore, Kathy Qi Cai, Wensi Tao, Elizabeth R Smith, Xiang-Xi Xu. Differential requirement for Dab2 in the development of embryonic and extra-embryonic tissuesBMC Developmental Biology 2013; 13(1) doi: 10.1186/1471-213X-13-39
5
Endocytic Adaptor Proteins in Health and Disease: Lessons from Model Organisms and Human MutationsCells 2019; 8(11): 1345 doi: 10.3390/cells8111345
6
Grégoire F. Le Bras, Kenneth J. Taubenslag, Claudia D. Andl. The regulation of cell-cell adhesion during epithelial-mesenchymal transition, motility and tumor progressionCell Adhesion & Migration 2012; 6(4): 365 doi: 10.4161/cam.21326
7
Ya-Fei Xu, Yan-Ping Mao, Ying-Qin Li, Xian-Yue Ren, Qing-Mei He, Xin-Ran Tang, Ying Sun, Na Liu, Jun Ma. MicroRNA-93 promotes cell growth and invasion in nasopharyngeal carcinoma by targeting disabled homolog-2Cancer Letters 2015; 363(2): 146 doi: 10.1016/j.canlet.2015.04.006
8
Gaoda Ju, Lingling Zhang, Wenting Guo, Hao Wang, Xin Zhang, Zhuanzhuan Mu, Yuqing Sun, Di Sun, Han Diao, Sen Miao, Yiran Chen, Tao Xing, Jun Liang, Yansong Lin, Wei Long Zhong. Identification and Validation of a Prognostic Signature Based on Methylation Profiles and Methylation-Driven Gene DAB2 as a Prognostic Biomarker in Differentiated Thyroid CarcinomaDisease Markers 2022; 2022: 1 doi: 10.1155/2022/1686316
9
Beata Pyrzynska, Iwona Pilecka, Marta Miaczynska. Endocytic proteins in the regulation of nuclear signaling, transcription and tumorigenesisMolecular Oncology 2009; 3(4): 321 doi: 10.1016/j.molonc.2009.06.001
10
Marc S. Penn. Are stem cells the teacher or the student?Current Opinion in Organ Transplantation 2012; 17(6): 663 doi: 10.1097/MOT.0b013e32835a5aad
11
XUE-MEI XIE, ZI-YIN ZHANG, LIAN-HE YANG, DA-LEI YANG, NA TANG, HUAN-YU ZHAO, HONG-TAO XU, QING-CHANG LI, EN-HUA WANG. Aberrant hypermethylation and reduced expression of disabled-2 promote the development of lung cancersInternational Journal of Oncology 2013; 43(5): 1636 doi: 10.3892/ijo.2013.2084
12
Joanna H Tong, David C Ng, Shuk L Chau, Ken K So, Patrick P Leung, Tin L Lee, Raymond W Lung, Michael W Chan, Anthony W Chan, Kwok W Lo, Ka F To. Putative tumour-suppressor gene DAB2is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinomaBMC Cancer 2010; 10(1) doi: 10.1186/1471-2407-10-253
13
Adèle Hannigan, Paul Smith, Gabriela Kalna, Cristiana Lo Nigro, Clare Orange, Darren I. O’Brien, Reshma Shah, Nelofer Syed, Lindsay C. Spender, Blanca Herrera, Johanna K. Thurlow, Laura Lattanzio, Martino Monteverde, Meghan E. Maurer, Francesca M. Buffa, Jelena Mann, David C.K. Chu, Catharine M.L. West, Max Patridge, Karin A. Oien, Jonathan A. Cooper, Margaret C. Frame, Adrian L. Harris, Louise Hiller, Linda J. Nicholson, Milena Gasco, Tim Crook, Gareth J. Inman. Epigenetic downregulation of human disabled homolog 2 switches TGF-β from a tumor suppressor to a tumor promoterJournal of Clinical Investigation 2010; 120(8): 2842 doi: 10.1172/JCI36125
14
Zoe K. Price, Noor A. Lokman, Masato Yoshihara, Hiroaki Kajiyama, Martin K. Oehler, Carmela Ricciardelli. Disabled-2 (DAB2): A Key Regulator of Anti- and Pro-Tumorigenic PathwaysInternational Journal of Molecular Sciences 2022; 24(1): 696 doi: 10.3390/ijms24010696
15
Alicia A. Tone, Carl Virtanen, Patricia Shaw, Theodore J. Brown. Prolonged Postovulatory Proinflammatory Signaling in the Fallopian Tube Epithelium May Be Mediated through a BRCA1/DAB2 AxisClinical Cancer Research 2012; 18(16): 4334 doi: 10.1158/1078-0432.CCR-12-0199
16
S Liu, N Zhu, H Chen. Expression patterns of human DAB2IP protein in fetal tissuesBiotechnic & Histochemistry 2012; 87(5): 350 doi: 10.3109/10520295.2012.664658
17
O. I. Kit, D. I. Vodolazhskiy, E. N. Kolesnikov, N. N. Timoshkina. Epigenetic markers of esophageal cancer: DNA methylationBiochemistry (Moscow), Supplement Series B: Biomedical Chemistry 2017; 11(1): 55 doi: 10.1134/S1990750817010048
18
Chang Li, Jun Chen, Tengfei Chen, Zhenlei Xu, Chun Xu, Cheng Ding, Yuxuan Wang, Jun Zhao, Chang Li, Zhe Lei, Hong-Tao Zhang, Jun Zhao, Chang Li, Zhe Lei, Hong-Tao Zhang, Jun Zhao. Aberrant Hypermethylation at Sites -86 to 226 of DAB2 Gene in Non-Small Cell Lung CancerThe American Journal of the Medical Sciences 2015; 349(5): 425 doi: 10.1097/MAJ.0000000000000436
19
J. Chen, D. L. Kwong, T. Cao, Q. Hu, L. Zhang, X. Ming, J. Chen, L. Fu, X. Guan. Esophageal squamous cell carcinoma (ESCC): advance in genomics and molecular geneticsDiseases of the Esophagus 2015; 28(1): 84 doi: 10.1111/dote.12088
20
Chang Li, Cheng Ding, Tengfei Chen, Jun Chen, Zhenlei Xu, Zhe Lei, Chun Xu, Jun Zhao. Micro ribonucleic acid‐93 promotes proliferation and migration of esophageal squamous cell carcinoma by targeting disabled 2Thoracic Cancer 2015; 6(4): 524 doi: 10.1111/1759-7714.12242
21
Antoine G. van der Heijden, Lourdes Mengual, Juan J. Lozano, Mercedes Ingelmo-Torres, Maria J. Ribal, Pedro L. Fernández, Egbert Oosterwijk, Jack A. Schalken, Antonio Alcaraz, J. Alfred Witjes. A five-gene expression signature to predict progression in T1G3 bladder cancerEuropean Journal of Cancer 2016; 64: 127 doi: 10.1016/j.ejca.2016.06.003
22
J C Martin, B-S Herbert, B A Hocevar. Disabled-2 downregulation promotes epithelial-to-mesenchymal transitionBritish Journal of Cancer 2010; 103(11): 1716 doi: 10.1038/sj.bjc.6605975
23
Jose A. Karam, Shahrokh F. Shariat, Hong-Ying Huang, Rey-Chen Pong, Raheela Ashfaq, Ellen Shapiro, Yair Lotan, Arthur I. Sagalowsky, Xue-Ru Wu, Jer-Tsong Hsieh. Decreased DOC-2/DAB2 Expression in Urothelial Carcinoma of the BladderClinical Cancer Research 2007; 13(15): 4400 doi: 10.1158/1078-0432.CCR-07-0287
24
Showket Hussain, Neha Singh, Irfana Salam, Kapil Bandil, M Yuvaraj, Mohammad Akbar Bhat, Mohammad Muzaffar Mir, Mushtaq A. Siddiqi, Ranbir C Sobti, Mausumi Bharadwaj, Bhudev C. Das. Methylation-mediated gene silencing of suppressor of cytokine signaling-1 (SOCS-1) gene in esophageal squamous cell carcinoma patients of Kashmir valleyJournal of Receptors and Signal Transduction 2011; 31(2): 147 doi: 10.3109/10799893.2011.553836
25
Wensi Tao, Robert Moore, Elizabeth R. Smith, Xiang-Xi Xu. Endocytosis and Physiology: Insights from Disabled-2 Deficient MiceFrontiers in Cell and Developmental Biology 2016; 4 doi: 10.3389/fcell.2016.00129
26
Ovidio Jiménez Martín, Andreas Schlosser, Rhoikos Furtwängler, Jenny Wegert, Manfred Gessler. MYCN and MAX alterations in Wilms tumor and identification of novel N-MYC interaction partners as biomarker candidatesCancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02259-2
27
Hong-Tao Xu, Lian-He Yang, Qing-Chang Li, Shu-Li Liu, Di Liu, Xue-Mei Xie, En-Hua Wang. Disabled-2 and Axin are concurrently colocalized and underexpressed in lung cancersHuman Pathology 2011; 42(10): 1491 doi: 10.1016/j.humpath.2011.01.004
28
Chen-Shuan Chung, Yi-Chia Lee, Cheng-Ping Wang, Jenq-Yuh Ko, Wen-Lun Wang, Ming-Shiang Wu, Hsiu-Po Wang. Secondary Prevention of Esophageal Squamous Cell Carcinoma in Areas Where Smoking, Alcohol, and Betel Quid Chewing are PrevalentJournal of the Formosan Medical Association 2010; 109(6): 408 doi: 10.1016/S0929-6646(10)60072-1
29
Carla V. Finkielstein, Daniel G. S. Capelluto. Disabled‐2: A modular scaffold protein with multifaceted functions in signalingBioEssays 2016; 38(S1) doi: 10.1002/bies.201670907
30
Shantel B. Ternes, Matthew J. Rowling. Vitamin D Transport Proteins Megalin and Disabled-2 Are Expressed in Prostate and Colon Epithelial Cells and Are Induced and Activated by All-Trans-Retinoic AcidNutrition and Cancer 2013; 65(6): 900 doi: 10.1080/01635581.2013.805422
31
O.I. Kit, D.I. Vodolazhskiy, E.N. Kolesnikov, N.N. Timoshkina. Epigenetic markers of esophageal cancer: DNA methylationBiomeditsinskaya Khimiya 2016; 62(5): 520 doi: 10.18097/PBMC20166205520
32
Yujuan Yang, Qingxia Zhang, Feng Xu, Chunkang Chang, Xiao Li. Aberrant promoter methylation of Dab2 gene in myelodysplastic syndromeEuropean Journal of Haematology 2012; 89(6): 469 doi: 10.1111/ejh.12014
33
Chien‐Ling Huang, Ju‐Chien Cheng, Kenji Kitajima, Toru Nakano, Chun‐Fung Yeh, Kowit‐Yu Chong, Ching‐Ping Tseng. Disabled‐2 is required for mesoderm differentiation of murine embryonic stem cellsJournal of Cellular Physiology 2010; 225(1): 92 doi: 10.1002/jcp.22200
34
Andrew M. Kaz, William M. Grady. Epigenetic biomarkers in esophageal cancerCancer Letters 2014; 342(2): 193 doi: 10.1016/j.canlet.2012.02.036
35
Carla V. Finkielstein, Daniel G. S. Capelluto. Disabled‐2: A modular scaffold protein with multifaceted functions in signalingBioEssays 2016; 38(S1) doi: 10.1002/bies.201670907
36
Jaroslaw Paluszczak, Katarzyna Kiwerska, Daniela Mielcarek-Kuchta. Frequent methylation of DAB2, a Wnt pathway antagonist, in oral and oropharyngeal squamous cell carcinomasPathology - Research and Practice 2018; 214(2): 314 doi: 10.1016/j.prp.2017.12.010
37
Stella C. Ogbu, Phillip R. Musich, Jinyu Zhang, Zhi Q. Yao, Philip H. Howe, Yong Jiang. The role of disabled-2 (Dab2) in diseasesGene 2021; 769: 145202 doi: 10.1016/j.gene.2020.145202
38
Roman Muff, Ram Mohan Ram Kumar, Sander M. Botter, Walter Born, Bruno Fuchs. Genes Regulated in Metastatic Osteosarcoma: Evaluation by Microarray Analysis in Four Human and Two Mouse Cell Line SystemsSarcoma 2012; 2012: 1 doi: 10.1155/2012/937506
39
Xiao-Mei Zhang, Ming-Zhou Guo. The value of epigenetic markers in esophageal cancerFrontiers of Medicine in China 2010; 4(4): 378 doi: 10.1007/s11684-010-0230-3
40
Wen-Lun Wang, Wei-Lun Chang, Hsiao-Bai Yang, Yu-Chi Wang, I-Wei Chang, Ching-Tai Lee, Chi-Yang Chang, Jaw-Town Lin, Bor-Shyang Sheu. Low disabled-2 expression promotes tumor progression and determines poor survival and high recurrence of esophageal squamous cell carcinomaOncotarget 2016; 7(44): 71169 doi: 10.18632/oncotarget.8460
41
Milad Ashrafizadeh, Masoud Najafi, Reza Mohammadinejad, Tahereh Farkhondeh, Saeed Samarghandian. Flaming the fight against cancer cells: the role of microRNA-93Cancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-01349-x
42
Paulette Mhawech-Fauceglia, Joshua Kesterson, Dan Wang, Stacey Akers, Nefertiti Chianti DuPont, Kimberly Clark, Shashikant Lele, Song Liu. Expression and clinical significance of the transforming growth factor-β signalling pathway in endometrial cancerHistopathology 2011; 59(1): 63 doi: 10.1111/j.1365-2559.2011.03892.x